AI assistant
Sending…
RESMED INC — Director's Dealing 2014
Apr 4, 2014
30071_dirs_2014-04-04_afaaeedd-0f89-4aec-934a-81b1deb283d5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-04-02
Reporting Person: Reiser Anne (President - ResMed Europe)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-04-02 | ResMed Common Stock | M | 17429 | $45.35 | Acquired | 77528.888 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-04-02 | ResMed Restricted Stock Units | $0 | M | 17429 | Disposed | ResMed Common Stock (17429) | Direct |
Footnotes
F1: Restricted stock units do not expire.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29